Inventurus Knowledge Solutions Limited (IKS) announced strong financial results for the third quarter and nine months ended December 31, 2025. The company reported a significant year-on-year revenue growth of 24%, reaching ₹8,150 million (₹815 crore) for the quarter. EBITDA saw a 40% increase year-on-year, and Profit After Tax (PAT) surged by 41% year-on-year to ₹1,833 million (₹183.3 crore). The company's Q3 FY26 performance highlights include a 4.3% sequential revenue growth and a 1.4% sequential growth in PAT. The EBITDA margin stood at 35%, with a PAT margin of 22%. Sachin K. Gupta, Founder & Global CEO, attributed the strong performance to the effectiveness of their Care Enablement Platform in addressing the US healthcare market's cost, quality, and access pressures. He also noted advancements in AI capabilities, particularly in the Patient Engagement suite. Nithya Balasubramanian, Group CFO, emphasized the consistent ability to drive profitable growth and deliver value, attributing margin expansion to operating leverage, technology deployment, and cost management. The company also highlighted several business developments, including new partnerships with StrideCare and VitalMD Group Holding & Femwell, an expansion with a top 5 health system, and a new partnership with a Behavioral Health System. In terms of recognitions, IKS Health received the 2026 Best in KLAS Award for Virtual Scribing Services for the second consecutive year, and Mr. Sachin K. Gupta received the 'ET Edge Impactful CEO Award'.
